AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31190497
Drug: Intradermal needling
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal needling combined with rehabilitation intervention
Trial: 28279484
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg per day)
Trial: 28279484
Drug: Prednisolone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (0.5 mg/kg per day)
Trial: 26164786
Drug: Lercanidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine 10 mg/valsartan 80 mg (L10/V80)
Trial: 26164786
Drug: Lercanidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine 10 mg/valsartan 160 mg (L10/V160)
Trial: 26164786
Drug: Lercanidipine 20
RxNorm normalized name: lercanidipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine 20 mg/valsartan 160 mg (L20/V160)
Trial: 26164786
Drug: Lercanidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine 10 mg (L10)
Trial: 21641636
Drug: Cetuximab added
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab added to oxaliplatin and fluoropyrimidine chemotherapy (arm B)
Trial: 21641636
Drug: Oxaliplatin and
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin and fluoropyrimidine chemotherapy alone (arm A)
Trial: 19209478
Drug: Thoracic spine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic spine thrust manipulation plus electro-thermal therapy for 5 treatment sessions
Trial: 19209478
Drug: Electro-thermal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electro-thermal therapy for 5 treatment sessions
Trial: 16416224
Drug: pantoprazole, 40
RxNorm normalized name: Pantoprazole, 40 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pantoprazole, 40 mg
Trial: 16416224
Drug: omeprazole, 20
RxNorm normalized name: Omeprazole, 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole, 20 mg
Trial: 9366668
Drug: Ganciclovir implant
RxNorm normalized name: ganciclovir Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir implant exchange (second implant)
Trial: 9366668
Drug: Ganciclovir implant
RxNorm normalized name: ganciclovir Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir implant exchange (third implant)
Trial: 3895098
Drug: Chemoimmunotherapy (CIT:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoimmunotherapy (CIT: plus allogeneic Neuraminidase‐treated blasts in high dosage)
Trial: 3895098
Drug: Cyclic chemotherapy
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic chemotherapy (CT) alone
Trial: 3895098
Drug: Chemoimmunotherapy (CIT)
RxNorm normalized name: Cit
DrugBank: Citrulline (DB00155)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemoimmunotherapy (CIT) for patients receiving more than 2 cycles of maintenance therapy
Trial: 31211327
Drug: Medical Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical Therapy
Trial: 20154337
Drug: Eprosartan on
RxNorm normalized name: Eprosartan only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan on top of other anti-hypertensive drugs (n = 47)
Trial: 20154337
Drug: Other anti-hypertensive
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other anti-hypertensive drugs alone (n = 50)
Trial: 14870884
Drug: Bicarbonate/lactate solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate/lactate solution (25 mmol/L bicarbonate and either 10 or 15 mmol/L lactate)
Trial: 14870884
Drug: Bicarbonate/lactate 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate/lactate 35 mmol/L
Trial: 14870884
Drug: Higher calcium
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher calcium (1.75 mmol/L) lactate/bicarbonate solution
Trial: 14870884
Drug: Standard lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard lactate solutions (35 or 40 mmol/L)
Trial: 15251661
Drug: Insulin doses
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin doses greater than 30 units
Trial: 6895626
Drug: sucralfate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucralfate (1 g, 0.5 h before each meal and at bedtime)
Trial: 6895626
Drug: cimetidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cimetidine (300 mg, 0.5 h before each meal and at bedtime)
Trial: 29949505
Drug: Ethanol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (120 ml of vodka followed by 60 ml of vodka)
Trial: 28444115
Drug: Treatment arm
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment arm with more responders
Trial: 17121590
Drug: BDP HFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP HFA 100 microg twice daily
Trial: 17121590
Drug: BDP CFC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP CFC 100 microg twice daily
Trial: 17121590
Drug: BDP CFC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDP CFC 200 microg twice daily
Trial: 17121590
Drug: Inter-period comparisons
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inter-period comparisons of active treatments
Trial: 15085875
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment and best supportive care
Trial: 11346432
Drug: Oral DFMO
RxNorm normalized name: DFMO
DrugBank: Eflornithine (DB06243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral DFMO at daily dosages between 0.075 and 0.4 g/m(2) for 12 months
Trial: 9720660
Drug: DHEA (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (50 mg qd p.o. for 4 consecutive days starting 2 days before immunization)
Trial: 4694690
Drug: New Lanoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New Lanoxin tablets
Trial: 4694690
Drug: Old Lanoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Old Lanoxin tablets
Trial: 30576772
Drug: BT-11 (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BT-11 (300 mg daily)
Trial: 27183377
Drug: Hydroxychloroquine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (200 mg oral twice daily) plus pegylated interferon alfa‐2a (160 μg subcutaneous once weekly) plus ribavirin (1000–1200 mg/day) for 12 weeks
Trial: 27183377
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care therapy (pegylated interferon alfa‐2a plus ribavirin) for 12 weeks
Trial: 19462921
Drug: Fluroben 100
RxNorm normalized name: Fluroxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluroben 100 mg tablet
Trial: 19462921
Drug: Originator product
RxNorm normalized name: Sucrets Original Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Originator product 100 mg tablet
Trial: 17993031
Drug: One daily
RxNorm normalized name: One Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One daily varnish application (G1)
Trial: 17993031
Drug: Two daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two daily varnish applications with a 15-minute interval (G2)
Trial: 17993031
Drug: Two daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two daily varnish applications with a 5-hour interval (G3)
Trial: 17993031
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (G4) - no varnish treatment
Trial: 11054515
Drug: Sulphasalazine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulphasalazine (500 mg, two tablets twice daily)
Trial: 28158151
Drug: 0.075% capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075% capsaicin cream
Trial: 3856501
Drug: Isotretinoin 80
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin 80 mg
Trial: 3856501
Drug: Isotretinoin 160
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin 160 mg
Trial: 3856501
Drug: Isotretinoin 240
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin 240 mg
Trial: 3856501
Drug: Isotretinoin 320
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin 320 mg
Trial: 25889643
Drug: Polydextrose (PDX)
RxNorm normalized name: Polydextrose
DrugBank: Polydextrose (DB14836)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polydextrose (PDX) 12.5 g or 15 g
Trial: 9222648
Drug: Tolbutamide treatment
RxNorm normalized name: Tolbutamide
DrugBank: Tolbutamide (DB01124)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tolbutamide treatment for approximately 10 years
Trial: 31420055
Drug: Acetaminophen (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (650 mg) + Oxycodone (10 mg)
Trial: 31420055
Drug: Acetaminophen (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (650 mg) only
Trial: 29415828
Drug: Bacillus cereus
RxNorm normalized name: Bacillus cereus
DrugBank: Bacillus cereus (DB19245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus cereus A 05 (4 vials with 5 mL × 10^6 every 6 hours)
Trial: 29415828
Drug: Soluble fiber
RxNorm normalized name: Soluble fiber
DrugBank: Methylcellulose (DB11228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble fiber (10 g every 8 hours)
Trial: 25153575
Drug: l-thyroxine (l-T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: l-thyroxine (l-T4) supplementation at a dose of 5 μg/kg/day
Trial: 25153575
Drug: Untreated group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Untreated group (no l-T4 supplementation)
Trial: 20890243
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone for 3 days postoperatively (Group 1)
Trial: 20890243
Drug: No systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No systemic steroid treatment (Group 2)
Trial: 14982551
Drug: High-dose fluoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fluoxetine (60 mg)
Trial: 14982551
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for smoking cessation
Trial: 9572066
Drug: L-carnitine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (5 grams intravenously over 2 hours, twice daily for 5 consecutive days; 10 grams in 1500 ml cardioplegia administered through the aortic root after aortic cross-clamping)
Trial: 10150550
Drug: Morphine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine plus diazepam
Trial: 27654496
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) for child PTSD
Trial: 26727041
Drug: Metyrapone (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metyrapone (500 mg twice daily)
Trial: 25523407
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy (fluid, with and without dobutamine)
Trial: 22114899
Drug: Iscucin® Populi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iscucin® Populi (IP) strength G (0.25%)
Trial: 22114899
Drug: Placebo (isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (isotonic solution)
Trial: 18609065
Drug: Bradykinin (BK)
RxNorm normalized name: dimethicone
DrugBank: Bradykinin (DB12126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bradykinin (BK) group received 25 microg bradykinin infusion for 7 minutes before cardiopulmonary bypass (CPB)
Trial: 6701925
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of chemotherapy and radiotherapy
Trial: 9388514
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of new drugs and radiotherapy
Trial: 2286468
Drug: Fosfomycin trometamol
RxNorm normalized name: trometamol
DrugBank: Tromethamine (DB03754)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin trometamol (3 g single oral dose)
Trial: 2286468
Drug: Pipemidic acid
RxNorm normalized name: pipemidic acid
DrugBank: Pipemidic acid (DB13823)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipemidic acid (400 mg twice daily for five days)
Trial: 7013868
Drug: Chemotherapy protocol
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy protocol combining adriamycin (40 mg/m2 on day 1), vincristine (1.2 mg/m2 on day 2), cyclophosphamide (400 mg/m2 on days 3, 4, 5), 5 fluorouracil (500 mg/m2 on days 3, 4, 5) followed by cyclophosphamide (100 mg/m2/day for 7 days), melphalan (2.5 mg/m2/day for 7 days), methotrexate (25 mg/m2/week for 3 weeks) with 3 applications of living BCG
Trial: 7013868
Drug: Chemotherapy protocol
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy protocol without BCG
Trial: 26546067
Drug: ACHD-CARE intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACHD-CARE intervention (group psychosocial intervention delivered during eight 90-minute weekly sessions)
Trial: 16449211
Drug: Atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 20 mg/day for 1 week (group B)
Trial: 16449211
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy (group A)
Trial: 11772156
Drug: Collagenase-containing ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagenase-containing ointment (Novuxol)
Trial: 7942234
Drug: Orange juice
RxNorm normalized name: Orange juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orange juice (1 litre daily)
Trial: 3281997
Drug: Ketotifen, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen, 1 mg in the evening during 1 week
Trial: 3281997
Drug: Ketotifen, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen, 1 mg, twice daily, during 3 weeks
Trial: 27855265
Drug: AVG intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AVG intervention (Xbox 360), played twice per week for 60 minutes over 12 weeks
Trial: 24839883
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) at optimized doses of 30, 50, or 70 mg per day
Trial: 23331528
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray (MFNS) 100 μg once or twice daily
Trial: 23331528
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray (MFNS) 200 μg once or twice daily
Trial: 20118486
Drug: Steroid exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid exposure
Trial: 18787325
Drug: Two-compound scalp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-compound scalp formulation (calcipotriol 50 microg/g plus betamethasone dipropionate 0.5 mg/g)
Trial: 18787325
Drug: Calcipotriol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol (50 microg/g)
Trial: 12832684
Drug: Fluticasone 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone 1000 micro g
Trial: 12832684
Drug: Beclomethasone 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone 1000 micro g
Trial: 10973837
Drug: Eptifibatide treatment
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide treatment in patients with significant CAD
Trial: 10973837
Drug: Eptifibatide treatment
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide treatment in patients with mild CAD
Trial: 10973837
Drug: Eptifibatide treatment
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide treatment in patients with no CAD
Trial: 3099944
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g amoxycillin syrup
Trial: 24373307
Drug: 3 dose
RxNorm normalized name: Hep A, ped/adol, 3 dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 dose IM priming schedule
Trial: 23770132
Drug: Azathioprine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (2.5 mg · kg(‐1) · day(‐1))
Trial: 16319477
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid prednicarbat plus wet‐wrap dressing
Trial: 16319477
Drug: Topical corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroid prednicarbat alone
Trial: 10830159
Drug: Explanatory therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Explanatory therapy
Trial: 10830159
Drug: Waiting list
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting list followed by explanatory therapy
Trial: 8841149
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 mg)
Trial: 8841149
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 to 4 mg)
Trial: 8841149
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 mg) with caffeine (1%)
Trial: 8841149
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 mg) during vasomotor phenomena
Trial: 8841149
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 mg) with fenoxazoline
Trial: 8841149
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 mg) during acute viral rhinitis
Trial: 1370568
Drug: Intravenous procaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous procaine and low‐molecular‐weight dextran
Trial: 6129077
Drug: Prazosin and
RxNorm normalized name: prazosin and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin and Phenoxybenzamine (chronic therapy)
Trial: 31451249
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml apple vinegar per day for 8 weeks
Trial: 26897443
Drug: Intravenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous insulin (regular insulin)
Trial: 20432399
Drug: sc enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sc enoxaparin with protocol-mandated IV enoxaparin bolus (0.3 mg/kg)
Trial: 12450026
Drug: Dynamic autoregulatory
RxNorm normalized name: water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic autoregulatory index (ARI) tests performed every 12 hours during the first 5 days postinjury and daily during the next 5 days
Trial: 7778318
Drug: Camonagrel (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Camonagrel (800 mg orally)
Trial: 7778318
Drug: Camonagrel (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Camonagrel (10 mg/kg i.v.) in cats
Trial: 7778318
Drug: Aspirin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (50 mg/kg i.v.) pretreatment
Trial: 7778318
Drug: L-NAME (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NAME (100 micrograms/kg/min, i.v.) pretreatment
Trial: 12952369
Drug: 17beta‐estradiol 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta‐estradiol 2 mg plus norethisterone acetate 1 mg (E2/NETA)
Trial: 12952369
Drug: conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: conjugated equine estrogen 0.625 mg (CEE)
Trial: 12952369
Drug: raloxifene HCI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: raloxifene HCI 60 mg
Trial: 12952369
Drug: non‐users of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: non‐users of replacement therapy
Trial: 11075556
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg.kg‐1
Trial: 11075556
Drug: Ketamine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1.0 mg.kg‐1
Trial: 11075556
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution 5 ml (control group)